Health ❯ Healthcare ❯ Cancer

Immunotherapy

mRNA Vaccines Pembrolizumab Immune Checkpoint Inhibitors Checkpoint Inhibitors Clinical Trials Side Effects Personalized Medicine CAR-T Therapy Amphiregulin CAR-T Cell Therapy Durvalumab Atezolizumab Oncolytic Virus Therapy Patient Experiences TIM-3 Research Keytruda Biomarkers Neoantigen Therapy Chimeric Antigen Receptor (CAR) Vaccimel Pediatric Cancer Treatment Therapeutic Vaccines T-cell Therapy Regulatory T Cells Cancer Vaccines Natural Killer Cells

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

Investigators will test causation in randomized multi‑center trials following preclinical evidence of an immune‑priming effect.

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

Adjuvant Pembrolizumab Cuts Risk of Distant Metastases in Merkel Cell Carcinoma at ESMO 2025

NICE Approves Keytruda Combo for Advanced Endometrial Cancer on NHS

Meta-Analysis Shows 43% Overall Response for Fecal Transplants Combined with Cancer Immunotherapy

Phase 3 Trial Launches to Test Electric Field and Immunotherapy Combo in Glioblastoma

Atezolizumab-Enhanced Chemotherapy Halves Recurrence in Stage III dMMR Colon Cancer

Study Finds NAD Decline Drives Age-Related CAR-T Cell Therapy Failures